Form 4: Director Melenikiotou Acquires Shares of Inspire Medical Systems in Lieu of Cash Fees
SEC Form 4 Filing
Georgia Melenikiotou, a director of Inspire Medical Systems, acquired 32 shares of common stock on July 15, 2024, in lieu of cash fees.
Summary
- On July 15, 2024, Georgia Melenikiotou, a director of Inspire Medical Systems, acquired 32 shares of common stock.
- The shares were received in lieu of cash fees, as per the company's Non-Employee Director Compensation Policy.
- The price per share was $138.58.
- Following the transaction, Melenikiotou directly owns 2,134 shares of Inspire Medical Systems.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine transaction, and the director taking shares in lieu of cash is a mildly positive signal.
Positives
- The director's decision to take shares in lieu of cash may signal confidence in the company's future performance.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it involves a small number of shares.
Key Dates
| Date | Description |
|---|---|
| 07/15/2024 | Date of transaction: Georgia Melenikiotou acquired 32 shares of common stock. |
| 07/17/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.